Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSE:8309
TSE:8309Banks

Sumitomo Mitsui Trust Group (TSE:8309) Non Performing Loan Improvement Challenges Bearish Risk Views

Sumitomo Mitsui Trust Group (TSE:8309) has just posted its Q3 2026 numbers, with total revenue of ¥403.9 billion and basic EPS of ¥135.88, alongside trailing twelve month EPS of ¥422.33 and net income of ¥298.32 billion. Over recent quarters, revenue has moved between ¥324.4 billion in Q2 2025 and ¥422.9 billion in Q3 2025, while quarterly EPS has ranged from ¥44.50 in Q4 2025 to ¥135.88 in the latest period. This is likely to prompt investors to focus on how these earnings translate into the...
NYSE:CALX
NYSE:CALXCommunications

Calix (CALX) Is Down 17.6% After Record 2025 Results and Expanded Buyback Amid Margin Pressure

Calix, Inc. reported past fourth-quarter 2025 revenue of US$272.45 million and net income of US$7.21 million, capping a full-year revenue of US$1.00 billion and net income of US$17.88 million, while also expanding its share repurchase authorization to US$425 million and advancing its broadband platform adoption. An interesting angle is how Calix’s record results coincide with rising cloud transition costs and a larger buyback program, highlighting a tension between near-term margin pressure...
TSX:BITF
TSX:BITFSoftware

Bitfarms (TSX:BITF) Is Down 16.4% After U.S. Pivot And Leverage Shift Has The Bull Case Changed?

In late January 2026, Bitfarms was downgraded by Keefe Bruyette, while also reshaping its operations by exiting Latin America and appointing Edie Hofmeister as Chair of the Board to support its move to the United States. These shifts come as U.S. regulators intensify oversight of the cryptocurrency sector, placing Bitfarms’ capital decisions and location choices under closer scrutiny. With the company’s recent share price decline, we’ll explore how rising leverage influences Bitfarms’...
NYSE:AA
NYSE:AAMetals and Mining

Is Alcoa’s (AA) Aggressive 2026 Output Plan Reshaping Its Vertically Integrated Aluminum Strategy?

In January 2026, Alcoa reported higher 2025 aluminum production and sharply stronger annual earnings, while issuing 2026 guidance that points to increased alumina and aluminum output driven by productivity gains and smelter restarts. An interesting detail is that Alcoa plans to ship more alumina and aluminum than it produces in 2026, highlighting the role of trading activity and externally sourced material in meeting customer demand across its vertically integrated chain. Next, we’ll examine...
NYSE:PSX
NYSE:PSXOil and Gas

A Look At Phillips 66 (PSX) Valuation As Refining Progress Draws Investor Attention Before Q4 Results

Why Phillips 66 (PSX) is back on investor radar Fresh commentary around Phillips 66 (PSX) points to progress in its Refining Segment, with cost cuts, higher clean product yields and record utilization intersecting with access to discounted Canadian and Venezuelan heavy crude. For investors, the focus now shifts to whether this mix of operational improvement and feedstock pricing can be sustained or clarified when the company releases its upcoming Q4 results. See our latest analysis for...
NasdaqGS:ILMN
NasdaqGS:ILMNLife Sciences

A Look At Illumina (ILMN) Valuation As Recent Returns Contrast With Longer Term Declines

Recent performance context for Illumina stock Illumina (ILMN) has drawn investor attention after a 1-month return of 7.8% and a past 3-month return of 20.7%, alongside a 1-year total return of 9.1% and a 3-year total return showing a 30.5% decline. See our latest analysis for Illumina. At a share price of $144.81, Illumina has recently seen short term momentum cool, with a 1 day share price return of 3.26% decline and a 7 day share price return of 3.64% decline. Its 1 year total shareholder...
TSE:6961
TSE:6961Electronic

Enplas (TSE:6961) Margin Improvement To 11.9% Tests Rich Valuation Narratives

How Enplas (TSE:6961) Q3 2026 Numbers Set Up the Next Chapter Enplas (TSE:6961) has put fresh numbers on the table for Q3 2026, with revenue of ¥11.5b and basic EPS of ¥182.61, backed by trailing twelve month EPS of ¥558.30 and net income of ¥4,947m. The company has seen revenue move from ¥9.1b in Q2 2025 to ¥11.5b in Q3 2026. Over the same span, quarterly basic EPS shifted from ¥65.20 to ¥182.61, giving investors a clear view of how the top line and per share earnings have tracked through...
OM:ARJO B
OM:ARJO BMedical Equipment

Arjo (OM:ARJO B) Margin Compression To 3% Challenges Bullish Earnings Growth Narrative

Arjo (OM:ARJO B) has wrapped up FY 2025 with Q4 revenue of SEK 2.8b and Basic EPS of SEK 0.26, capping a year in which trailing 12 month revenue came in at SEK 11.0b and EPS at SEK 1.23. The company has seen quarterly revenue move from SEK 2.99b in Q4 2024 to SEK 2.81b in Q4 2025, while quarterly EPS shifted from SEK 0.64 to SEK 0.26 over the same period. This sets up a picture where investors are likely to focus on how margins are holding up against the headline growth forecasts. See our...
TSX:EFR
TSX:EFROil and Gas

Is Energy Fuels (TSX:EFR) Trading Uranium Stability for Capital-Heavy Rare Earths Ambitions?

In late January 2026, Energy Fuels confronted confusion around a U.S. Department of Energy nuclear innovation initiative while investors weighed its rising uranium sales, rare earth ambitions, and elevated cash burn. An updated feasibility study for the Toliara rare earths project in Madagascar, with a projected US$1.80 billions NPV, underscores how Energy Fuels is tying its future to critical minerals and Western supply-chain security. We’ll now examine how this DOE policy...
NasdaqGS:HQY
NasdaqGS:HQYHealthcare

How HealthEquity’s GARP Profile and Accelerating Earnings Narrative At HealthEquity (HQY) Has Changed Its Investment Story

Recently published analyst research highlighted HealthEquity as a leading provider of technology-enabled healthcare spending solutions with solid growth characteristics and financial strength, operating in a market supported by structural tailwinds. What stands out is HealthEquity’s identification as a Growth at a Reasonable Price candidate, where accelerating earnings trends intersect with valuation metrics that appear attractive relative to peers. We’ll now examine how HealthEquity’s GARP...
NYSE:CHD
NYSE:CHDHousehold Products

A Look At Church & Dwight (CHD) Valuation After Earnings Beat Guidance Dividend Hike And Buyback Completion

What moved Church & Dwight stock Church & Dwight (CHD) shares reacted to a cluster of updates, including fourth quarter and full year 2025 results, fresh 2026 guidance, a higher dividend, and confirmation of share repurchases. For full year 2025, Church & Dwight reported sales of US$6,203.2 million and net income of US$736.8 million. Diluted earnings per share from continuing operations were US$3.02. In the fourth quarter, sales were US$1,644.2 million, with net income of US$143.5 million...
NYSE:WHR
NYSE:WHRConsumer Durables

Whirlpool (WHR) Valuation Check After Cautious 2026 Outlook And Mixed 2025 Results

Whirlpool (WHR) is back in focus after its fourth quarter and full year 2025 update, where revenue missed Wall Street expectations despite solid earnings metrics. In addition, a cautious 2026 outlook weighed on investor sentiment. See our latest analysis for Whirlpool. The stock reaction has been choppy around these updates, with Whirlpool’s share price at US$79.99 after a 1-day share price return of 3.94%, a 30-day share price return of 10.88% and a 1-year total shareholder return of 19.05%...
TSE:7723
TSE:7723Electronic

Aichi Tokei Denki (TSE:7723) Margin Lift To 7.7% Tests Cautious Earnings Narratives

Aichi Tokei Denki (TSE:7723) Q3 2026 earnings snapshot Aichi Tokei Denki (TSE:7723) has reported fresh numbers for Q3 2026, with quarterly revenue of ¥14.1 billion and basic EPS of ¥91.68 backed by net income of ¥1.4 billion. The trailing twelve month figures show revenue of ¥57.0 billion, EPS of ¥284.26 and net income of ¥4.4 billion. Over the past six reported periods, the company’s quarterly revenue has moved between ¥13.3 billion and ¥15.4 billion, with basic EPS ranging from ¥36.42 to...
TSE:3512
TSE:3512Luxury

Nippon Felt (TSE:3512) Margin Uplift To 5.4% Tests Premium Valuation Narrative

Nippon Felt (TSE:3512) Q3 2026 earnings snapshot Nippon Felt (TSE:3512) reported Q3 2026 revenue of ¥2,326 million and basic EPS of ¥9.66, supported by net income of ¥171 million. The company has seen quarterly revenue move in a tight band between ¥2,326 million and ¥2,456 million over the past six quarters. Over the same period, basic EPS has ranged from ¥2.59 to ¥9.66 as net income shifted between ¥46 million and ¥171 million. With a 5.4% net profit margin over the last 12 months and...
NYSE:BIRK
NYSE:BIRKLuxury

A Look At Birkenstock (BIRK) Valuation After Investor Day Growth And Capacity Updates

Birkenstock Holding (BIRK) is back in focus after its Investor Day, where management discussed wholesale trends, production limits, and an expanded direct-to-consumer push, including 30 planned new stores in the Americas. See our latest analysis for Birkenstock Holding. Despite the Investor Day buzz, the share price has had a tougher run, with a 30 day share price return of a 7.68% decline and a 1 year total shareholder return of a 36.15% decline, pointing to momentum that has yet to fully...
NasdaqGS:FTAI
NasdaqGS:FTAITrade Distributors

FTAI Aviation Deepens CFM56 Engine Ties As Valuation Stays Rich

FTAI Aviation (NasdaqGS:FTAI) announced a multi year component and repair support agreement with CFM International for CFM56 engines. The agreement covers access to OEM parts, performance upgrades, and component repairs for CFM56 powerplants. This deal is focused on supporting the global fleet of CFM56 engines used on current generation narrowbody aircraft. For you as an investor, the key point is that FTAI Aviation is tightening its ties with a major engine manufacturer while focusing on...